MORGAN STANLEY - 31 Dec 2024 SCHEDULE 13G Report for Apellis Pharmaceuticals, Inc. Common Stock (APLS)

Filing Manager
MORGAN STANLEY
Reporting Manager
Morgan Stanley
Security
Apellis Pharmaceuticals, Inc. Common Stock
Symbol
APLS
Shares outstanding
124,581,182 shares
Disclosed Ownership
9,592,751 shares
Ownership
7.7%
Form type
SCHEDULE 13G
Filing time
03 Feb 2025, 13:09:31 UTC
Date of event
31 Dec 2024
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Morgan Stanley 7.7% 9,592,751 0 9,575,774 Christopher O'Hara Authorized Signatory, Morgan Stanley
Morgan Stanley Capital Services LLC 6.3% 7,803,185 0 7,803,185 Christopher O'Hara Authorized Signatory, Morgan Stanley Capital Services LLC